NOI to sole source under SAT.docx

DOCX document 23 KB Posted

Attached to
Notice of Intent to Sole Source – Therakos Inc. – Cellex USA Kits
Solicitation number
NOI-OD-26-010263
Issued by

About this file

This is a Notice of Intent to Sole Source a federal procurement from the National Institutes of Health Clinical Center. The procurement involves five cases of THERAKOS CELLEX Photopheresis System Procedural Kits, which are exclusively manufactured and sold by Therakos Inc. under the Cellex brand. The acquisition is being conducted under FAR Part 13 Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), which permits sole-source procurement for purchases not exceeding the Simplified Acquisition Threshold when only one source is reasonably available. This procurement is exempt from standard competition requirements under FAR Part 6.

The notice was posted on September 15, 2026, with a comment deadline of September 21, 2026, at 5:00 PM EST. No formal solicitation document or quotation request will be issued. Interested parties may submit comments referencing Notice Number NOI-OD-26-010263 to Ryssa Nix, Contract Specialist, at the NIH Clinical Center, Office of Purchasing and Contracts via email at Ryssa.nix@nih.gov. The procurement is classified under NAICS Code 423450 and PSC Code 6550. This notice indicates the government's intent to proceed with awarding the contract to Therakos Inc. as the sole source vendor.

View the file

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Notice Number: NOI-OD-26-010263 Title: Notice of Intent to Sole Source – Therakos Inc. – Cellex USA Kits Description:

This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.

This procurement is for five cases of THERAKOS® CELLEX® Photopheresis System Procedural Kits. These kits are only manufactured and sold by the Cellex equipment manufacturer Therakos.

This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 –Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.

Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Ryssa Nix, Contract Specialist via email to Ryssa.nix@nih.gov by close date.

Notice Type: Notice of Intent NAICS Code: 423450 PSC Code: 6550 Posted Date: 09/15/2026 Close Date: 09/21/2026 5pm EST End User IC: Clinical Center POC Name: Ryssa Nix Email Address: Ryssa.nix@nih.gov

File details come from the government source that posted it. Updated .